Q

Quest Diagnostics

Operates nationwide clinical laboratory testing

Executive Sales Director, Precision Oncology

Full-TimeUpdated on 10/23/2026
$210k - $250k/yr+ Sales Incentive Plan + Long-Term Incentives + Annual performance bonus
Expert
Bachelor's, MBA
Indianapolis, IN, USA+2 moreMore locations: Cleveland, OH, USA | Chicago, IL, USA
RemoteRemote role based in Chicago, Indianapolis, or Cleveland; travel across the Midwest is required.
Sales & Account ManagementField Sales

About the job

Requirements
  • A bachelor's degree is required; an MBA or advanced degree in Life Sciences is preferred.
  • At least 5 years of sales management experience specifically in oncology diagnostics, molecular pathology, or high-value medical sales.
  • A proven track record of driving performance in a collaborative, matrixed organization and managing multi-specialty sales loops with clinical empathy and precision.
  • Willingness to travel across the Midwest region to close major deals and support the front-line team.
Responsibilities
  • Lead, scale, and inspire a specialized sales team across the Midwest, with direct-line leadership over 9–10 Precision Oncology Account Executives executing a high-growth clinical strategy.
  • Lead commercial execution of the portfolio, primarily focusing on the tumor-informed minimal residual disease product.
  • Spearhead regional adoption of the tumor-informed minimal residual disease assay by converting key academic and community oncology accounts.
  • Attain regional goals for the Precision Oncology channel by specialty.
  • Hire, train, and certify oncology sales professionals, guiding them through performance structures and strategic career development.
  • Set metrics and accountability standards to drive performance toward goals.
  • Manage and measure sales-force performance and provide feedback to representatives.
  • Incorporate district analytics and market intelligence into plans.
  • Facilitate problem-solving and customer satisfaction.
  • Support key account development and collaborate on large deals.
  • Provide input to regional marketing plans.
  • Own functional strategic initiatives.

About the company

Q

Quest Diagnostics

View
Website

Quest Diagnostics provides clinical laboratory testing and diagnostic services. It processes patient samples across a network of laboratories to run a broad menu of 3,000+ tests, including cancer diagnostics and anatomical pathology, and delivers interpretive reports through its medical staff. Tests are performed at its patient service centers, esoteric and rapid-response labs, and outpatient facilities, with results shared with clinicians via connected data systems. What sets Quest Diagnostics apart is its scale and scope: the world’s largest clinical lab network, the broadest test menu, a large team of MDs and PhDs for interpretation, and leadership in cancer diagnostics and pre-employment drug testing, plus extensive clinical trials testing. Its goal is to empower healthcare providers and patients with actionable diagnostic insights to identify, treat, and manage disease, inspire healthy behaviors, and improve health outcomes.

Company Size

10,001+

Company Stage

IPO

Headquarters

Secaucus, New Jersey

Founded

1967

Get referred to Quest Diagnostics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Apple Health users will order Quest tests later in 2026, expanding direct-to-consumer reach.
  • Quest’s consumer-health business reached $250 million in 2025 and management targets 30% 2026 growth.
  • Quest will launch Roche pTau217 and its new multi-biomarker AD-Detect panel in Q4 2026.

What critics are saying

  • CMS cuts lab reimbursement up to 15% on January 1, 2027, hitting CMS revenue.
  • Quest faces NLRB case 14-CA-378210 over alleged discharge and coercive statements in St. Louis.
  • Repeated PAMA cuts and commoditized testing can squeeze Quest into a low-margin processing utility.

What makes Quest Diagnostics unique

  • Quest serves half of U.S. physicians and hospitals through 2,000 service centers.
  • Quest built a consumer-health platform with Apple Health, Oura, Hims & Hers, and Function Health.
  • Quest leads blood-based Alzheimer’s diagnostics with AD-Detect and Roche pTau217 launches in 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • 401(k) Company Match
  • Performance Bonus
  • Employee Stock Purchase Plan
  • Tuition Reimbursement
  • Wellness Program
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • 401(k) Retirement Plan

Growth & Insights and Company News

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Yahoo Finance
Oct 23rd, 2026
Quest Diagnostics and Waters partner on at-home cervical cancer screening kit

Quest Diagnostics and Waters Corporation have announced a collaboration to expand access to the Onclarity Self-Collection Kit for cervical cancer screening. Patients collect samples at home, and Quest laboratories process them using the Onclarity HPV assay. The companies aim to widen access to testing for patients who face barriers to screening in clinics. The move supports Quest's push into consumer health testing, a business of roughly $300 million. Quest has a market value of about $26.9 billion. The program is due to enter broader rollout in 2027. Reimbursement pressure remains a risk for the company.

Yahoo Finance
Oct 22nd, 2026
Quest Diagnostics lifts 2026 guidance as Q3 revenue climbs 10%, warns of 1% PAMA hit

Quest Diagnostics reported 10% revenue growth in the third quarter of 2026 and raised its full-year revenue and earnings per share guidance. Growth came from physician, hospital, and consumer channels, and organic volume rose 5% excluding major partnerships. Hospital revenue grew by double digits, helped by the Corewell Health partnership. Consumer health revenue is expected to grow more than 30% this year, as users can now order labs through the Apple Health app. The company expects a 2027 hit of about 1% of revenue from cuts under the Protecting Access to Medicare Act (PAMA), and less than 1.3% cumulatively through 2029. It is backing the RESULTS Act to reform PAMA, and plans to offset part of the impact through efficiency gains. Quest also disclosed a cybersecurity incident at a test ordering system, which it said has not materially disrupted operations.

FOX21 News Colorado
Oct 22nd, 2026
Quest Diagnostics reports cyber breach affecting 'certain patient records'

Quest Diagnostics reports cyber breach affecting 'certain patient records' by: Associated Press Posted: Oct 22, 2026 / 09:09 AM MDT Updated: Oct 22, 2026 / 09:13 AM MDT CHICAGO (AP) - Medical laboratory operator Quest Diagnostics said it learned of a cyber breach of one of its systems this week, likely compromising some records for patients. In a Thursday regulatory filing, Quest Diagnostics reported "unauthorized access" to its Quanum Lab Services Manager, a platform where certain clients can place test orders and receive or look up their results. The company said it discovered the hack on Wednesday and notified federal law enforcement. How many patients and which particular records have been affected is still unknown. Quest Diagnostics said it believes "certain patient records" were accessed in the breach, but that the full scope remains under investigation. The New Jersey-based company said it's also working with external cybersecurity experts to assist in its response. Quest Diagnostics has seen hacks impacting patient records before. In 2016, for example, the company said data including lab results and contact information of about 34,000 people was exposed in another online breach. And in 2019, other personal information belonging to about 11.9 million Quest patients was affected after a separate hack at American Medical Collection Agency, a billing collections service provider. Cyberattacks are on the rise across industries. Beyond healthcare, other breaches have recently disrupted anything from supermarket chains to core education applications. Governments and companies worldwide are working more broadly on online security updates. Urgency erupted this week, after an AI-assisted discovery of vulnerabilities in a programming language called PHP, which is vital to 70% of websites globally. Outages and limited service have continued for many as firms rush to patch those risks. But based on the company's investigation, Quest Diagnostics confirmed to The Associated Press Thursday that its cyber breach was not related to the PHP issue.

The Seattle Times
Oct 22nd, 2026
Quest Diagnostics reports cyber breach affecting 'certain patient records'

Quest Diagnostics reports cyber breach affecting 'certain patient records' Oct. 22, 2026 at 7:32 am The Associated Press CHICAGO (AP) - Medical laboratory operator Quest Diagnostics said it learned of a cyber breach of one of its systems this week, likely compromising some records for patients. In a Thursday regulatory filing, Quest Diagnostics reported "unauthorized access" to its Quanum Lab Services Manager, a platform where certain clients can place test orders and receive or look up their results. The company said it discovered the hack on Wednesday and notified federal law enforcement. How many patients and which particular records have been affected is still unknown. Quest Diagnostics said it believes "certain patient records" were accessed in the breach, but that the full scope remains under investigation. The New Jersey-based company said it's also working with external cybersecurity experts to assist in its response. Quest Diagnostics has seen hacks impacting patient records before. In 2016, for example, the company said data including lab results and contact information of about 34,000 people was exposed in another online breach. And in 2019, other personal information belonging to about 11.9 million Quest patients was affected after a separate hack at American Medical Collection Agency, a billing collections service provider. Cyberattacks are on the rise across industries. Beyond healthcare, other breaches have recently disrupted anything from supermarket chains to core education applications. Governments and companies worldwide are working more broadly on online security updates. Urgency erupted this week, after an AI-assisted discovery of vulnerabilities in a programming language called PHP, which is vital to 70% of websites globally. Outages and limited service have continued for many as firms rush to patch those risks. But based on the company's investigation, Quest Diagnostics confirmed to The Associated Press Thursday that its cyber breach was not related to the PHP issue. The Associated Press. See more Seattle Times content on Google The Seattle Times does not append comment threads to stories from wire services such as the Associated Press, The New York Times, The Washington Post or Bloomberg News. Rather, we focus on discussions related to local stories by our own staff. You can read more about our community policies here.

Yahoo Finance
Oct 22nd, 2026
Quest Diagnostics Q3 revenue rises 10% to $3.1B, beating estimates and lifting guidance

Quest Diagnostics (NYSE:DGX) beat Wall Street expectations in the third quarter, with revenue up 10% year on year to $3.1 billion. Analysts had expected $3.07 billion. Adjusted earnings per share were $3, 4.4% above estimates of $2.87 and up from $2.60 a year earlier. Sales volumes rose 14.5%, and operating margin climbed to 15.5% from 13.7%. The company raised its full-year adjusted EPS guidance to $11.30 at the midpoint. Full-year revenue guidance of $12.09 billion at the midpoint came in 0.6% above estimates. Chief executive officer Jim Davis credited strength across physician, hospital, and consumer channels, plus gains from automation and AI. Shares fell 1.8% to $234.67 after the results.